Related Experiment Video
Updated: Aug 10, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Modeling comorbidity of chronic diseases using coupled hidden Markov model with bivariate discrete copula
Zarina Oflaz1, Ceylan Yozgatligil2, A Sevtap Selcuk-Kestel3
1Department of Industrial Engineering, KTO Karatay University, Konya, Turkey.
Insights
This study models interacting chronic diseases using a coupled hidden Markov model. The approach effectively captures disease comorbidity dynamics from population data, even without clinical information.
Area of Science:
- Biostatistics
- Epidemiology
- Computational Biology
Background:
- Chronic diseases often interact and share risk factors, a phenomenon known as comorbidity.
- Comorbidity is crucial for accurate actuarial valuations and understanding disease progression.
- Existing models may not fully capture the complex dynamics of interacting chronic conditions.
Purpose of the Study:
- To develop a novel statistical model for analyzing parallel, interacting chronic disease processes.
- To introduce a coupled hidden Markov model (CHMM) integrated with bivariate discrete copula functions.
- To provide a method for estimating model parameters and addressing computational challenges.
Main Methods:
- Utilized a combination of hidden Markov theory and copula functions to model disease interactions.
- Developed a CHMM with a bivariate discrete copula within the hidden process.
- Employed a variational expectation-maximization (VEM) algorithm for parameter estimation.
- Addressed numerical underflow issues in forward-backward probability computations.
Main Results:
- Simulation studies demonstrated satisfactory performance of the proposed CHMM across different association levels.
- The model successfully defined the dependency structure and dynamics of unobserved disease data.
- Application to hospital appointment data showed the model's utility in analyzing comorbidity.
Conclusions:
- The proposed CHMM offers a robust framework for investigating disease comorbidity.
- The model is particularly valuable when analyzing population dynamics over time without access to clinical data.
- This approach enhances our understanding of complex disease interactions and their impact.
Abstract:
A range of chronic diseases have a significant influence on each other and share common risk factors. Comorbidity, which shows the existence of two or more diseases interacting or triggering each other, is an important measure for actuarial valuations. The main proposal of the study is to model parallel interacting processes describing two or more chronic diseases by a combination of hidden Markov theory and copula function. This study introduces a coupled hidden Markov model with the bivariate discrete copula function in the hidden process. To estimate the parameters of the model and deal with the numerical intractability of the log-likelihood, we use a variational expectation maximization algorithm. To perform the variational expectation maximization algorithm, a lower bound of the model's log-likelihood is defined, and estimators of the parameters are computed in the M-part. A possible numerical underflow occurring in the computation of forward-backward probabilities is solved. The simulation study is conducted for two different levels of association to assess the performance of the proposed model, resulting in satisfactory findings. The proposed model was applied to hospital appointment data from a private hospital. The model defines the dependency structure of unobserved disease data and its dynamics. The application results demonstrate that the model is useful for investigating disease comorbidity when only population dynamics over time and no clinical data are available.
Related Concept Videos
Causality in Epidemiology
Multicompartment Models: Overview
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results...
Mechanistic Models: Compartment Models in Individual and Population Analysis

